|Last Price||Today's Change||52-Week Range||Trading Volume|
|2.44 CAD||-0.04 (-1.61%)||2.19 - 11.50||1.5 thousand (Below Avg)|
Market data as of 12:49PM 11/26/15. Quotes are delayed by at least 15 min.
Transition Therapeutics to Host Investor Day November 23 in New York
PR Newswire - Thursday 11/19/2015 11:45 AM ET
Transition Therapeutics Announces First Quarter Fiscal 2016 Financial Results
PR Newswire - Tuesday 11/10/2015 4:01 PM ET
Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2016 Financial Results on Tuesday, November 10th, at 4:30 P.M. EST
PR Newswire - Monday 11/02/2015 6:01 AM ET
Transition Therapeutics Announces Agreement for Phase 2 Study of TT701 Drug Candidate
PR Newswire - Thursday 10/29/2015 4:01 PM ET
Transition Therapeutics Announces Presentation of ELND005 Phase 2/3 Clinical Study Results at Clinical Trials in Alzheimer's Disease (CTAD) Conference
PR Newswire - Wednesday 10/28/2015 6:01 AM ET
|Revenue Growth (1yr)||--|
|Net Income Growth (1yr)||--|
Data is delayed by at least 15 min.